| David Douglas Fisher, LP | |
|
514 Beltrami Ave Nw, Bemidji, MN 56601-3010 | |
| (218) 444-2845 | |
| (218) 444-2847 |
| Full Name | David Douglas Fisher |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 514 Beltrami Ave Nw, Bemidji, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093921967 | NPI | - | NPPES |
| 164M3FI | Other | MN | BCBS OF MINNESOTA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | LP3535 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David Douglas Fisher, LP 514 Beltrami Ave Nw, Bemidji, MN 56601-3010 Ph: (218) 444-2845 | David Douglas Fisher, LP 514 Beltrami Ave Nw, Bemidji, MN 56601-3010 Ph: (218) 444-2845 |
News Archive
Tasmanian Devil Salem died at age seven but made a difference to her endangered species. Only 50 micrograms of her tissue was taken and processed by Australian genetic scientist Elizabeth Murchison, using new US technology, to produce the first devil genome sequence. As a result, the fight against devil facial tumor disease now has a draft DNA reference map. This was presented at a genetic conference in Hobart yesterday.
The continual postponement of the SGR cuts has dampened the enthusiasm of younger cardiologists, said Robert O. Bonow, MD, director of the Center for Cardiovascular Innovation at Northwestern University Feinberg School of Medicine.
Vanderbilt-Ingram Cancer Center investigators have uncovered a mechanism that helps explain how lithium, a drug widely used to treat bipolar mood disorder, also protects the brain from damage that occurs during radiation treatments.
Celladon Corporation and Momentum Research, Inc. today announced completion of enrollment of the phase 2 double-blind portion of the Calcium Up-regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) trial. Momentum Research is Celladon's consulting and management organization with clinical expertise in the development of cardiovascular products and trials.
China Medicine Corporation announced today that it obtained a patent from Australia Patent Office for recombinant Aflatoxin Detoxifizyme (rADTZ). The patent is valid through January 13, 2025.
› Verified 3 days ago
Dr. Lloyd E Rootes, LP, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 514 Beltrami Ave Nw, Bemidji, MN 56601 Phone: 218-444-2845 Fax: 218-444-2847 | |
Douglas A Lewandowski, L.P. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6008 Shady Ln Ne, Bemidji, MN 56601 Phone: 218-444-3224 | |
Russell F Lee, E.D., LP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 722 15th St Nw, Bemidji, MN 56601 Phone: 218-751-3280 Fax: 218-751-3298 | |
Dr. Lindsay Allyn Yates Plumer, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 112 1st St W, Bemidji, MN 56601 Phone: 218-888-8032 | |
Dr. Patricia Jane Hunter, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 112 1st St W, Bemidji, MN 56601 Phone: 218-888-8032 Fax: 218-888-8033 | |
Amy J Donnan Neppl, MA, LP Psychologist Medicare: Medicare Enrolled Practice Location: 1705 Anne St Nw, Bemidji, MN 56601 Phone: 218-333-2158 Fax: 218-333-5033 |